BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20190101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200504
DTEND;VALUE=DATE:20200508
DTSTAMP:20260515T084336
CREATED:20191215T133346Z
LAST-MODIFIED:20191215T133426Z
UID:23365-1588550400-1588895999@www.pharmajournalist.com
SUMMARY:NASH Summit Boston
DESCRIPTION:The NASH Summit offers a wide range of cutting-edge debates across 4 conference tracks: discovery\, translational\, non-invasive biomarker and clinical drug development\, in addition to a selection of workshops and seminars. This convivial discussion and networking forum has an extensive program set to help you approach your pipeline for the upcoming year. \n \nJoin 80+ speakers\, including our conference Chair Jason Campagna\, Senior Vice President & Global NASH Lead at Intercept\, and 350+ attendees as the community comes together again by addressing their challenges and the consequences of change in the NASH market. \n\nEstablish a plan of action to optimize candidate success by evaluating advances and difficulties and learn from the community’s experience\nTranslate anti-fibrotic efficacy into the clinic by learning about ground-breaking preclinical modalities\nUse the latest practical insights into hepatocyte differentiation to improve your target identification by understanding its impact on immune cells\, ductular reaction and fibrosis\nExamine the payer’s thoughts on the need to biopsy and assess the clinical utility of non-invasive diagnostics in the normal algorithm of care\nConnect NASH reduction in phase 2 and NASH resolution in phase 3 while justifying a systemic approach to address NASH in combination\, as a manifestation of wider metabolic dysfunction\n\nDownload the full event guide or get in touch today for the agenda and speaker line-up!
URL:https://www.pharmajournalist.com/event/nash-summit-boston/
LOCATION:50 Park Plaza at Arlington Street\, Boston\, MA\, 02116-3912\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR